NOVA

0.375

(%)

OTHERS THE DRUG CONTROL AUTHORITY MINISTRY OF HEALTH MALAYSIA APPROVES NOVA HEPAR-P CAPSULE WITH MODERN CLAIM FOR LIVER SUPPORT

NOVA WELLNESS GROUP BERHAD

Type Announcement
Subject OTHERS
Description
THE DRUG CONTROL AUTHORITY MINISTRY OF HEALTH MALAYSIA APPROVES NOVA HEPAR-P CAPSULE WITH MODERN CLAIM FOR LIVER SUPPORT

The Board of Directors of Nova Wellness Group Berhad wishes to announce that the Drug Control Authority Ministry of Health Malaysia has approved Nova Hepar-P Capsule with a modern claim for liver support. 

Please refer to the attachment for details.

This announcement is dated on 4 October 2024.




Please refer attachment below.

Attachments

Announcement.pdf
80.7 kB



Announcement Info

Company Name NOVA WELLNESS GROUP BERHAD
Stock Name NOVA
Date Announced 04 Oct 2024
Category General Announcement for PLC
Reference Number GA1-04102024-00038